203 related articles for article (PubMed ID: 28669452)
1. Metaplastic breast carcinoma: Analysis of 31 cases from a single institute.
Fayaz S; Demian GA; Eissa HE; Amanguno H; Abuzalouf S
J Egypt Natl Canc Inst; 2017 Sep; 29(3):141-145. PubMed ID: 28669452
[TBL] [Abstract][Full Text] [Related]
2. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors on outcomes in metaplastic breast cancer.
Leyrer CM; Berriochoa CA; Agrawal S; Donaldson A; Calhoun BC; Shah C; Stewart R; Moore HCF; Tendulkar RD
Breast Cancer Res Treat; 2017 Oct; 165(3):499-504. PubMed ID: 28689362
[TBL] [Abstract][Full Text] [Related]
4. Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute.
Hasbay B; Bolat FA; Aytaç HÖ; Aslan H; Purbager A
Turk Patoloji Derg; 2020; 36(1):23-30. PubMed ID: 31769499
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
Barnes PJ; Boutilier R; Chiasson D; Rayson D
Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
[TBL] [Abstract][Full Text] [Related]
6. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Radiological Features with Long Term Follow Up of Metaplastic Carcinoma Breast in India.
Puri G; Lohani KR; Khadka S; Kataria K; Ranjan P; Hari S; Mathur S; Dhar A; Srivastava A
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3483-3492. PubMed ID: 34837903
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
Nelson RA; Guye ML; Luu T; Lai LL
Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
[TBL] [Abstract][Full Text] [Related]
9. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of metaplastic breast carcinoma: A single-center experience.
Ertas G; Başal FB; Üçer AR; Benzer E; Altundağ MB; Demirci U; Çetin B; Karatas F
J Cancer Res Ther; 2020; 16(6):1229-1234. PubMed ID: 33342778
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
12. Metaplastic breast cancer: clinical significance.
Beatty JD; Atwood M; Tickman R; Reiner M
Am J Surg; 2006 May; 191(5):657-64. PubMed ID: 16647355
[TBL] [Abstract][Full Text] [Related]
13. A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.
Cimino-Mathews A; Verma S; Figueroa-Magalhaes MC; Jeter SC; Zhang Z; Argani P; Stearns V; Connolly RM
Am J Clin Pathol; 2016 Mar; 145(3):365-72. PubMed ID: 27124919
[TBL] [Abstract][Full Text] [Related]
14. Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).
Yu JI; Choi DH; Huh SJ; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Kim JH; Cho J; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Apr; 15(2):e105-15. PubMed ID: 25459069
[TBL] [Abstract][Full Text] [Related]
15. Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours.
Rakha EA; Tan PH; Shaaban A; Tse GM; Esteller FC; van Deurzen CH; Purnell D; Stotter A; Chan T; Yamaguchi R; Dodwell D; Jager A; Soler MT; Juneinah E; Plaza ML; Hodi Z; McCulloch T; Lee AH; Ellis IO
Breast; 2013 Feb; 22(1):13-8. PubMed ID: 23084962
[TBL] [Abstract][Full Text] [Related]
16. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
17. Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
Salemis NS
Breast Dis; 2018; 37(3):169-175. PubMed ID: 29504519
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic carcinoma of breast: A case series of seven patients from a tertiary care center and review of literature.
Benson R; Madan R; Julka PK; Rath GK
Gulf J Oncolog; 2016 May; 1(21):74-6. PubMed ID: 27250894
[TBL] [Abstract][Full Text] [Related]
20. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]